MAP2 over-expression has been shown in malignant diseases such as cutaneous melanoma [14], pulmonary carcinoid tumor and small cell carcinoma [15] and it has been correlated with cell motility and invasion in epithelial and oral cancer cells [16]. This evidence concerns the gene MAP2 and lip and oral cavity carcinoma.